Literature DB >> 22664815

Correlation between NT proBNP and left ventricular ejection fraction in elderly patients presenting to emergency department with dyspnoea.

Amulya C Belagavi1, Medha Rao, Aslam Y Pillai, U S Srihari.   

Abstract

OBJECTIVE: Shortness of breath is a common complaint for which the elderly seek medical attention in the emergency department (ED). Differentiating cardiac from respiratory causes of dyspnoea in this population is quite a challenge. N Terminal pro brain-natriuretic-peptide (NT proBNP) has been studied extensively as a biomarker of left ventricular (LV) failure.
METHODS: The NT proBNP was measured in 100 patients above 60 years of age who presented to the ED with shortness of breath. The level was compared with echocardiographic findings to assess correlation with ejection fraction (EF).
RESULTS: The NT proBNP values increased significantly as the functional severity of heart failure (HF) increased (P < 0.001). The mean NT proBNP level was 1503.33 pg/mL. Patients with respiratory causes of dyspnoea had a mean NT proBNP level of 309.28 pg/mL with normal LV function.
CONCLUSION: The NT proBNP levels had a good correlation with worsening LVEF.
Copyright © 2012 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22664815      PMCID: PMC3860605          DOI: 10.1016/S0019-4832(12)60091-1

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


  17 in total

1.  Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study.

Authors:  H Smith; R M Pickering; A Struthers; I Simpson; D Mant
Journal:  BMJ       Date:  2000-04-01

2.  Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP.

Authors:  Andreas Luchner; Christian Hengstenberg; Hannelore Löwel; Günter A J Riegger; Heribert Schunkert; Stephan Holmer
Journal:  Hypertension       Date:  2005-06-06       Impact factor: 10.190

3.  Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea.

Authors:  L Katherine Morrison; Alex Harrison; Padma Krishnaswamy; Radmila Kazanegra; Paul Clopton; Alan Maisel
Journal:  J Am Coll Cardiol       Date:  2002-01-16       Impact factor: 24.094

4.  The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.

Authors:  James L Januzzi; Carlos A Camargo; Saif Anwaruddin; Aaron L Baggish; Annabel A Chen; Daniel G Krauser; Roderick Tung; Renee Cameron; J Tobias Nagurney; Claudia U Chae; Donald M Lloyd-Jones; David F Brown; Stacy Foran-Melanson; Patrick M Sluss; Elizabeth Lee-Lewandrowski; Kent B Lewandrowski
Journal:  Am J Cardiol       Date:  2005-04-15       Impact factor: 2.778

5.  Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department.

Authors:  Peter A McCullough; Judd E Hollander; Richard M Nowak; Alan B Storrow; Philippe Duc; Torbjørn Omland; James McCord; Howard C Herrmann; Philippe G Steg; Arne Westheim; Cathrine Wold Knudsen; William T Abraham; Sumant Lamba; Alan H B Wu; Alberto Perez; Paul Clopton; Padma Krishnaswamy; Radmila Kazanegra; Alan S Maisel
Journal:  Acad Emerg Med       Date:  2003-03       Impact factor: 3.451

6.  Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.

Authors:  Alan S Maisel; Padma Krishnaswamy; Richard M Nowak; James McCord; Judd E Hollander; Philippe Duc; Torbjørn Omland; Alan B Storrow; William T Abraham; Alan H B Wu; Paul Clopton; Philippe G Steg; Arne Westheim; Catherine Wold Knudsen; Alberto Perez; Radmila Kazanegra; Howard C Herrmann; Peter A McCullough
Journal:  N Engl J Med       Date:  2002-07-18       Impact factor: 91.245

7.  Plasma brain natriuretic peptide concentration: impact of age and gender.

Authors:  Margaret M Redfield; Richard J Rodeheffer; Steven J Jacobsen; Douglas W Mahoney; Kent R Bailey; John C Burnett
Journal:  J Am Coll Cardiol       Date:  2002-09-04       Impact factor: 24.094

8.  Impact of history of heart failure on diagnostic and prognostic value of BNP: results from the B-type Natriuretic Peptide for Acute Shortness of Breath Evaluation (BASEL) study.

Authors:  Tujana Boldanova; Markus Noveanu; Tobias Breidthardt; Mihael Potocki; Tobias Reichlin; Anne Taegtmeyer; Michael Christ; Kirsten Laule; Claudia Stelzig; Christian Mueller
Journal:  Int J Cardiol       Date:  2009-01-29       Impact factor: 4.164

9.  B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study.

Authors:  Peter A McCullough; Richard M Nowak; James McCord; Judd E Hollander; Howard C Herrmann; Philippe G Steg; Philippe Duc; Arne Westheim; Torbjørn Omland; Cathrine Wold Knudsen; Alan B Storrow; William T Abraham; Sumant Lamba; Alan H B Wu; Alberto Perez; Paul Clopton; Padma Krishnaswamy; Radmila Kazanegra; Alan S Maisel
Journal:  Circulation       Date:  2002-07-23       Impact factor: 29.690

10.  B-type natriuretic peptide in cardiovascular disease.

Authors:  James A de Lemos; Darren K McGuire; Mark H Drazner
Journal:  Lancet       Date:  2003-07-26       Impact factor: 79.321

View more
  3 in total

1.  A Randomized Controlled Trial to Study the Effect of Yoga Therapy on Cardiac Function and N Terminal Pro BNP in Heart Failure.

Authors:  Bandi Hari Krishna; Pravati Pal; Gk Pal; J Balachander; E Jayasettiaseelon; Y Sreekanth; Mg Sridhar; Gs Gaur
Journal:  Integr Med Insights       Date:  2014-04-01

2.  Systemic Inflammation and Cardio-Renal Organ Damage Biomarkers in Middle Age Are Associated With Physical Capability Up to 9 Years Later.

Authors:  Diana Kuh; Rachel Cooper; Naveed Sattar; Paul Welsh; Rebecca Hardy; Yoav Ben-Shlomo
Journal:  Circulation       Date:  2019-04-23       Impact factor: 29.690

3.  Factors influencing left ventricular ejection fraction in patients with coronary microvascular disease and obstructive coronary artery disease.

Authors:  Henry Anselmo Mayala; Magesa Mafuru; Abdalah Mkangala; Mark Mayala; Pedro Pallangyo; Dickson Minja; Mohamed Janabi; Wang Zhao-Hui
Journal:  BMC Res Notes       Date:  2020-03-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.